Citation Information :
Parveen N. Hepatic and Gastrointestinal Manifestations of Urea Cycle Defect: A Perspective. Ann Pediatr Gastroenterol Hepatol 2024; 6 (3):39-41.
Urea cycle defect (UCD) has widely been studied for its clinical manifestation as an acute metabolic crisis. Now with the advancement in medical sciences, the survival rate of such cases has increased and has led us to know more about the varied acute and chronic clinical presentation. Here with this article, we aim to highlight some gastrointestinal manifestations of UCD.
Enns GM. Neurologic damage and neurocognitive dysfunction in urea cycle disorders. Semin Pediatr Neurol 2008;15:132–139. DOI: 10.1016/j.spen.2008.05.007
Dionisi-Vici C, Rizzo C, Burlina AB, et al. Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr 2002;140:321–327. DOI: 10.1067/mpd.2002.122394
Wilcken B. Problems in the management of urea cycle disorders. Mol Genet Metab 2004;81(Suppl 1):S86–S91. DOI: 10.1016/j.ymgme.10.016
Bachmann C. Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur J Pediatr 2003;162:410–416. DOI: 10.1007/s00431-003-1188-9
Harada E, Nishiyori A, Tokunaga Y, et al. Late-onset ornithine transcarbamylase deficiency in male patients: prognostic factors and characteristics of plasma amino acid profile. Pediatr Int 2006;48:105–111. DOI: 10.1111/j.1442-200X.2006.02181.x
Uchino T, Endo F, Matsuda I. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J Inherit Metab Dis 1998;21(Suppl 1):151–159. DOI: 10.1023/a:1005374027693
Nicolaides P, Liebsch D, Dale N, et al. Neurological outcome of patients with ornithine carbamoyltransferase deficiency. Arch Dis Child 2002;86:54–56. DOI: 10.1136/adc.86.1.54
Brusilow SW, Maestri NE. Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr 1996;43:127–170. DOI: 10.1016/S0065-3101(24)00072-0
Laemmle A, Gallagher RC, Keogh A, et al. Frequency and pathophysiology of acute liver failure in ornithine transcarbamylase deficiency (OTCD). PLoS One 2016;11:e0153358. DOI: 10.1371/journal.pone.0153358
Yaplito-Lee J, Chow CW, Boneh A. Histopathological findings in livers of patients with urea cycle disorders. Mol Genet Metab 2013;108:161–165. DOI: 10.1016/j.ymgme.2013.01.006
Ranucci G, Rigoldi M, Cotugno G, et al. Chronic liver involvement in urea cycle disorders. J Inherit Metab Dis 2019;42(6):1118–1127. DOI: 10.1002/jimd.12144
Bigot A, Tchan MC, Thoreau B, et al. Liver involvement in urea cycle disorders: a review of the literature. J Inherit Metab Dis 2017;40:757–769. DOI: 10.1007/s10545-017-0088-5
Prada CE, Kaul A, Hopkin RJ, et al. Recurrent pancreatitis in ornithine transcarbamylase deficiency. Mol Genet Metab 2012;106(4):482–484. DOI: 10.1016/j.ymgme.2012.06.005
